Yes, tirzepatide injections can be prescribed online when a licensed clinician reviews your health history and decides treatment is appropriate. Tirzepatide is a prescription medication, so approval is not automatic. Online options may include brand-name products or compounded tirzepatide through licensed 503A pharmacies, with different costs, forms, and oversight.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →Can you get tirzepatide injections online?
Yes. Tirzepatide injections can be prescribed through telehealth when a licensed clinician determines they are appropriate after a medical review. The key is that the process must be clinical, not just a checkout page.
Tirzepatide is a prescription drug. FDA-approved tirzepatide products include Zepbound for chronic weight management in certain adults and Mounjaro for adults with type 2 diabetes, each under its approved labeling 3, 4. Compounded tirzepatide may also be prescribed by clinicians and filled by state-licensed 503A compounding pharmacies, but compounded medications are not FDA-approved.
At Chia, patients can start with an online eligibility review for tirzepatide injections and tablets. A licensed US provider reviews the health questionnaire and prescribes only when clinically appropriate. A prescription is never guaranteed.
What is tirzepatide and how does it work?
Tirzepatide is a dual GIP and GLP-1 receptor agonist. That means it activates two hormone pathways: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor.
These pathways help regulate appetite, satiety, gastric emptying, and blood glucose after meals 1. In plain English: tirzepatide may help some people feel full sooner, feel hungry less often, and improve blood sugar control. It is not a stand-alone guarantee of weight loss; in clinical trials, it was studied along with lifestyle changes 2.
Brand names matter because they point to different FDA-reviewed products. Zepbound is tirzepatide approved for chronic weight management in adults with obesity or adults with overweight and at least one weight-related condition, used with reduced-calorie diet and increased physical activity 3. Mounjaro is tirzepatide approved to improve blood sugar control in adults with type 2 diabetes, used with diet and exercise 4.
Compounded tirzepatide is different. It may contain the same active ingredient name, but it is not the same product as Zepbound or Mounjaro, and it does not have FDA-evaluated outcomes data as a compounded formulation. The safety focus should be licensed care: a real clinician review and a state-licensed compounding pharmacy, not no-prescription “research” sellers.
Who may be eligible for tirzepatide through an online provider?
Eligibility depends on your health history, weight-related goals, current medications, and risk factors. Online approval is not automatic, because tirzepatide can be a poor fit for some patients.
Clinicians commonly review body mass index, weight-related conditions, diabetes history, prior weight-loss medication use, pregnancy status, gallbladder or pancreas history, kidney issues, and medication interactions. FDA labeling for tirzepatide products includes warnings and precautions that clinicians use when weighing risks and benefits 3, 4.
A provider may also ask about symptoms that need in-person care or labs. Examples include severe abdominal pain, uncontrolled vomiting, dehydration risk, very high blood sugar symptoms, or complex endocrine history. Online care can be convenient, but it should still feel like medical care.
- A licensed clinician should review your health history before prescribing.
- The medication should be prescribed only if appropriate for your risks and goals.
- Side effects and follow-up should be part of the plan.
- You should know whether the medication is brand-name or compounded before paying.
How does an online tirzepatide prescription process usually work?
A safe online process has 4 core steps: intake, clinician review, prescription fulfillment if appropriate, and follow-up. The goal is to make care easier to access without skipping medical judgment.
- 1Complete a health questionnaire or telehealth visit. You share your medical history, medications, goals, and relevant symptoms.
- 2A licensed clinician reviews eligibility. This is where the provider decides whether tirzepatide makes sense or whether another plan is safer.
- 3If appropriate, the prescription is sent or fulfilled. Brand-name medications may go through a retail or mail-order pharmacy. Compounded tirzepatide may be filled by a state-licensed 503A compounding pharmacy.
- 4Follow-up continues over time. Your care team should review side effects, progress, refills, and any clinician-guided dose changes.
Gradual dose escalation has been used in tirzepatide clinical trials and FDA-approved labeling to support tolerability, especially because gastrointestinal side effects are common 2, 3. That is not a dosing instruction for you; your prescriber decides what is appropriate.
3-min quiz
See if tirzepatide may be appropriate for you
Chia offers compounded tirzepatide through an online visit, licensed US provider review, and home delivery when prescribed. A prescription requires a medical evaluation and is not guaranteed. Compounded medications are not FDA-approved.
Tirzepatide injections online at Chia: clinician-reviewed care and home delivery
At Chia, tirzepatide access starts online and stays clinician-guided. We offer compounded tirzepatide injections and tirzepatide tablets, with microdosing plans available when a provider finds treatment appropriate.
The process is simple: you complete a short health questionnaire, a licensed US provider reviews it, and medication is prescribed only when clinically appropriate. If prescribed, medication is compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door. Patients can message their care team through the patient portal between visits.
| Chia tirzepatide form | How it may fit | Current starting price |
|---|---|---|
| Injection | For patients who prefer the studied subcutaneous injection route and are comfortable with injections | Plans currently start at $299/month |
| Tablets | For patients who prefer a non-injection option when a provider finds it appropriate | Plans currently start at $249/month |
| Microdosing plans | Provider-guided lower-dose strategies may be available for some patients | See the tirzepatide product page for current details |
Some patients also ask about pairing weight treatment with energy or muscle-support goals. Chia offers Weight + Energy, which includes NAD+ injection plus a choice of GLP-1, and Weight + Muscle, which includes sermorelin injection plus a choice of GLP-1. These protocols still require provider review and are prescribed only when appropriate.
How much do tirzepatide injections cost online?
Costs vary because brand-name tirzepatide, insurance coverage, cash-pay programs, and compounded tirzepatide are priced differently. At Chia, tirzepatide injections currently start at $299/month and tirzepatide tablets currently start at $249/month.
Before paying for a 1-month or 3-month supply, ask what is included. Some programs separate the medication price from clinician visits, refill reviews, supplies, shipping, or follow-up. Others bundle more of the care into one price.
- Is the listed price for medication only, or does it include clinician review?
- Does the price include supplies, shipping, and refill support?
- Is it a 1-month plan, 3-month plan, or subscription?
- What happens if side effects occur or a dose change is needed?
- Is the product brand-name tirzepatide or compounded tirzepatide?
For up-to-date Chia pricing, review the tirzepatide product page. Prices can change over time, and eligibility still depends on provider review.
What is the difference between brand-name Zepbound, Mounjaro, and compounded tirzepatide?
Zepbound, Mounjaro, and compounded tirzepatide are related, but they are not the same product. The main difference is FDA approval status, labeled use, and how the medication is made and fulfilled.
| Option | Active ingredient | FDA approval status | Common use context | Fulfillment path |
|---|---|---|---|---|
| Zepbound | Tirzepatide | FDA-approved brand-name product | Chronic weight management in eligible adults, with diet and physical activity 3 | Retail, mail-order, or manufacturer-supported pharmacy channels |
| Mounjaro | Tirzepatide | FDA-approved brand-name product | Blood sugar control in adults with type 2 diabetes, with diet and exercise 4 | Retail, mail-order, or manufacturer-supported pharmacy channels |
| Compounded tirzepatide via 503A pharmacy | Tirzepatide, prepared as a compounded prescription | Not FDA-approved | May be prescribed when a licensed clinician finds it clinically appropriate | State-licensed 503A compounding pharmacy, often with home shipping |
Compounded tirzepatide should not be described as a generic version of Zepbound or Mounjaro. It also should not borrow brand-name trial results as if those results prove outcomes for a compounded formulation. The clinical evidence is strongest for tirzepatide as studied in trials and reviewed in FDA-approved products; compounded formulations have not been FDA-evaluated for safety, effectiveness, or quality.
Patients often compare tirzepatide with semaglutide, another incretin-based medication. Wegovy is semaglutide approved for chronic weight management, Ozempic is semaglutide approved for type 2 diabetes, and compounded semaglutide is a separate compounded option through licensed 503A pharmacies when prescribed. Semaglutide acts mainly on the GLP-1 receptor, while tirzepatide acts on both GIP and GLP-1 receptors 1, 5.
Are tirzepatide injections safe to start online?
Online prescribing can be appropriate when it includes a real clinician review, safety screening, and follow-up. Safety depends on the care model, the pharmacy source, and whether your risks are reviewed before treatment.
In SURMOUNT-1, tirzepatide was studied as a subcutaneous injection in adults with obesity or overweight with weight-related conditions, and average weight loss was greater than placebo; individual results vary 2. In the same trial program and FDA labeling, gastrointestinal side effects such as nausea, diarrhea, vomiting, constipation, abdominal pain, and decreased appetite were common 2, 3.
FDA-approved tirzepatide labels include warnings and precautions that clinicians review, including risks related to thyroid C-cell tumors, pancreatitis, gallbladder disease, acute kidney injury, hypoglycemia when used with insulin or insulin secretagogues, serious hypersensitivity, and severe gastrointestinal disease 3, 4. This is why a questionnaire should ask more than your height and weight.
What should you ask before choosing an online tirzepatide provider?
Ask questions that show whether the program is medical care or just a transaction. A good online provider should be clear about clinician review, pharmacy fulfillment, side-effect support, and what happens after the first month.
- Is a licensed US clinician reviewing my case?
- Is medication prescribed only if clinically appropriate?
- What pharmacy fills the prescription, and is it state-licensed?
- Is the medication brand-name or compounded?
- If compounded, will the provider avoid claiming it is FDA-approved or equivalent to a brand product?
- How are side effects, refills, and clinician-guided dose changes handled?
- Will I have a way to message the care team between visits?
At Chia, our model is built around those points: online intake, licensed provider review, provider-guided dosing, US 503A pharmacy compounding, home delivery, and patient-portal messaging. If treatment is not appropriate, our providers do not prescribe.
3-min quiz
Start your online tirzepatide visit
If you’re considering tirzepatide, Chia can help you complete an online eligibility review for tirzepatide injections or tablets. A licensed provider will review your information and prescribe only when clinically appropriate. Compounded medications are not FDA-approved.
FAQ: tirzepatide injections online
Yes, if a licensed clinician reviews your health history and decides tirzepatide is appropriate. A prescription is not automatic, and the provider may recommend another plan if safety concerns come up.
It depends on your medical history, weight-related goals, medications, and risk factors. Online providers should screen for conditions and medicines that could make tirzepatide less appropriate or require closer monitoring.
The cost depends on whether the medication is brand-name or compounded, whether insurance applies, and what the online program includes. At Chia, tirzepatide injections currently start at $299/month and tablets currently start at $249/month, so patients should check the product page for current pricing and plan details.
Yes, many online programs offer home shipping when medication is prescribed. At Chia, prescribed compounded medications are filled by state-licensed 503A compounding pharmacies and shipped to the patient’s door.
No. Zepbound is an FDA-approved brand-name tirzepatide product. Compounded tirzepatide is not FDA-approved, is not a generic of Zepbound, and should not be described as equivalent to a brand product.
Some patients may need lab work or in-person evaluation before or during treatment, depending on their health history and symptoms. The prescribing clinician decides what is needed.
Sometimes, but the decision should be clinician-guided. A provider will review your current medication, side effects, goals, medical history, and timing before deciding whether a switch is appropriate.
At Chia, tirzepatide is offered as injections and tablets, with microdosing plans available when clinically appropriate. The strongest human trial evidence for tirzepatide weight management is for subcutaneous injection, so patients should discuss form choice with their provider.
References
- 1.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
- 2.Karagiannis T, Avgerinos I, Liakos A, et al. Management of obesity with tirzepatide: a systematic review and meta-analysis. Obesity. 2023.
- 3.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. 2025.
- 4.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. 2025.
- 5.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2025.
- 6.Chen K, Yan Y, Zhao Y, et al. The effects of subcutaneous tirzepatide on obesity and overweight: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology. 2023.
- 7.U.S. Food and Drug Administration. Compounded drugs: questions and answers. 2024.
- 8.ClinicalTrials.gov. A clinical trial using tirzepatide to help people with obesity or overweight lose weight and maintain weight loss, NCT07284511. 2026.
- 9.American Diabetes Association Professional Practice Committee. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes—2026. Diabetes Care. 2026.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
